MINNEAPOLIS & BOSTON– Agiliti Inc. (NYSE: AGTI) (“Agiliti”), a nationwide provider of medical technology management and service solutions to the healthcare industry, today announced the closing of its acquisition by an affiliate of private equity firm Thomas H. Lee Partners, L.P. (“THL”).
On February 26, 2024, Agiliti announced that THL had signed a definitive agreement to purchase all outstanding shares of Agiliti common stock not currently owned by THL and its affiliates or certain management and director shareholders for $10.00 per share, implying a total enterprise value of $2.5 billion.
“The work we do at Agiliti has strengthened our nation’s healthcare system for more than 85 years,” said Tom Leonard, CEO of Agiliti. “While the business has evolved, our team has remained singularly focused on serving the needs of our customers and their patients with medical device products and services that enable safer and more efficient care. We look forward to an ongoing partnership with THL as we continue advancing our important mission.”
As a result of the closing of the transaction, trading of Agiliti common stock has been suspended on the New York Stock Exchange (the “NYSE”) and Agiliti has requested that its common stock be delisted from the NYSE.
Centerview Partners LLC acted as exclusive financial advisor to the Special Committee of the Board of Directors of Agiliti (the “Special Committee”). Weil, Gotshal & Manges LLP acted as legal counsel to the Special Committee. Goldman Sachs & Co. LLC acted as exclusive financial advisor to THL. Ropes & Gray LLP acted as legal counsel to THL.
